DOI:

Kartagener's Syndrome

Annick Weustink1,MD; Eleni C. Vourvouri1,2, MD, PhD; Michail I. Papafaklis2, MD; Georgios Sianos2*, MD, PhD

A 46-year-old man with Kartagener’s Syndrome (primary ciliary diskinesia, autosomal recessive disorder with dextrocardia, situs inversus, bronchiectasis and paranasal sinusitis) presented with new onset angina. Coronary arteriography revealed severe three-vessel disease with occluded left anterior descending and circumflex coronary arteries. Due to severe pulmonary disease, coronary artery bypass surgery was not considered as the first therapeutic option. He underwent successful percutaneous multivessel revascularisation with implantation of paclitaxel-eluting stents. Control coronary angiography nine months after the procedure revealed no signs of restenosis. The patient remains asymptomatic at two years.

Figure 1. Dual source 64 multi-slice computed tomography volume-rendered image of the heart and the thoracic cage demonstrating the dextrocardia.

AA: ascending aorta; DA: descending aorta; LAD: left anterior descending; LCx: left circumflex; PA: pulmonary artery; RCA: right coronary artery; RI: ramus intermedius; A: anterior; L: left; P: posterior; R: right

Figure 2. Dual source 64 multi-slice computed tomography volume-rendered image of the lungs depicting the extensive bronchiectasis.
MB: main bronchus; L: left; R: right

Figure 3. Left heart ventriculography (a) and post-procedural simultaneous left and right coronary arteriography (b) in left anterior oblique projection showing the long axis of the heart.

AA: ascending aorta; LAD: left anterior descending; LCx: left circumflex; LV: left ventricle; RCA: right coronary artery; RI: ramus intermedius; S: spine

Online data supplement

Video 1. Angiography coronaries

Video 2. Angiography left ventricle

Video 3. MSCT coronaries

Video 4. MSCT dextrocardia

Volume 3 Number 2
Aug 20, 2007
Volume 3 Number 2
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00027 Jul 7, 2025
Antithrombotic strategies after TAVI in light of cerebral microembolism
Dangas G and Nicolas J
free

Editorial

10.4244/EIJ-E-25-00028 Jul 7, 2025
The challenge of interpreting comparative TAVI studies
Rosseel L et al
free

Editorial

10.4244/EIJ-E-25-00024 Jul 7, 2025
The new balloon-expandable Myval transcatheter heart valve: only good news?
Pibarot P and Van Belle E
free

Debate

10.4244/EIJ-E-25-00019 Jul 7, 2025
Colchicine benefits are overestimated and current recommendations are too strong: pros and cons
Bainey K and Rossello X

Original Research

10.4244/EIJ-D-24-00966 Jul 7, 2025
Intra- versus supra-annular self-expanding transcatheter heart valves in small aortic annuli
Yamamoto M et al

Original Research

10.4244/EIJ-D-24-01112 Jul 7, 2025
Four-year durability of the Myval balloon-expandable transcatheter aortic valve
Jain A et al

Research Correspondence

10.4244/EIJ-D-24-01113 Jul 7, 2025
Restenosis patterns after percutaneous coronary intervention with drug-coated balloons for de novo coronary lesions
Matsuda K et al
Trending articles
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
65.55

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
42

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
26.5

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved